Zaki-Metias Kaitlin M, McKee Hayley, Applewhaite Christopher, Davis Margot K, Keyes Mira, LeVasseur Nathalie, Nguyen Elsie T, Seely Jean M, Yong-Hing Charlotte J
Department of Radiology, Trinity Health Oakland Hospital/Wayne State University School of Medicine, Pontiac, MI, USA.
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Can Assoc Radiol J. 2025 Feb;76(1):94-104. doi: 10.1177/08465371241262292. Epub 2024 Jul 23.
Breast arterial calcifications (BAC) on mammography have been correlated with increased cardiovascular risk. The Canadian Society of Breast Imaging released a position statement on BAC reporting in January 2023. This study evaluates the awareness of the clinical significance of BAC and reporting preferences of referring physicians in Canada. A 15-question survey was distributed to Canadian physicians who may review mammography results via regional and subspecialty associations and on social media following local institutional ethical approval. Responses were collected over 10 weeks from February to April 2023. Seventy-two complete responses were obtained. We are unable to determine the response rate, given the means of distribution. Only 17% (12/72) of responding physicians were previously aware of the association between BAC and increased cardiovascular risk, and 51% (37/72) preferred the inclusion of BAC in the mammography report. Fifty-six percent (40/72) indicated that BAC reporting would prompt further investigation, and 63% (45/72) would inform patients that their mammogram showed evidence of BAC. Sixty-nine percent (50/72) would find grading of BAC beneficial and 71% (51/72) agreed that there is a need for national guidelines. Less than a quarter of responding Canadian referring physicians were previously aware of the association between BAC and cardiovascular risk, although half of respondents indicated a preference for BAC reporting on mammography. Most participating physicians would inform their patients of the presence of BAC and consider further cardiovascular risk management. There was consensus that a national BAC grading system and clinical management guidelines would be beneficial.
乳腺钼靶检查中的乳腺动脉钙化（BAC）与心血管疾病风险增加相关。加拿大乳腺影像学会于2023年1月发布了一份关于BAC报告的立场声明。本研究评估了加拿大转诊医生对BAC临床意义的认知以及报告偏好。在获得当地机构伦理批准后，通过地区和专科协会以及社交媒体向可能会查看乳腺钼靶检查结果的加拿大医生发放了一份包含15个问题的调查问卷。在2023年2月至4月的10周内收集了回复。共获得72份完整回复。鉴于分发方式，我们无法确定回复率。只有17%（12/72）的回复医生之前知晓BAC与心血管疾病风险增加之间的关联，51%（37/72）的医生倾向于在乳腺钼靶检查报告中包含BAC。56%（40/72）的医生表示BAC报告将促使进一步检查，63%（45/72）的医生会告知患者其乳腺钼靶检查显示有BAC迹象。69%（50/72）的医生认为BAC分级有益，71%（51/72）的医生同意需要国家指南。不到四分之一的加拿大回复转诊医生之前知晓BAC与心血管疾病风险之间的关联，尽管一半的受访者表示倾向于在乳腺钼靶检查报告中报告BAC。大多数参与调查的医生会告知患者存在BAC，并考虑进一步进行心血管疾病风险管理。大家一致认为，国家BAC分级系统和临床管理指南将是有益的。
